Results 241 to 250 of about 20,614 (289)

Innovative diagnostische und therapeutische Optionen bei der linksventrikulären kardialen Hypertrophie [PDF]

, 2018
Beetz, Nick Lasse
core  

Efficacy and safety of sacubitril-valsartan in Maintenance Hemodialysis patients with hypertension:A retrospective study

Lili Jiang, Ran Jing, Yu Zhu, Pan Li, Bin Yang, Xin Ran, Ying Ran, Haifeng Ding, Jurong Yang, Shaofa Wu   +9 more
openalex   +2 more sources

Reduced Ejection Fraction of the Systemic Right Ventricle and Severe Tricuspid Regurgitation: Medication or Surgery? [PDF]

J Cardiovasc Dev Dis
Minaev AV, Danilov TY, Paraskevova DP, Dontsova VI, Trunina II, Samsonov VB, Tsoy SM, Voynov AS, Sarkisyan JA.   +8 more
europepmc   +1 more source

BOLD MRI to Evaluate the Effects of Sacubitril/Valsartan on Renal Protection in Type 2 Diabetics

Limin Zhai, Yue Wang, Xiang Li, Ling Ni, Deyuan Zhang, Tianrong Pan   +5 more
openalex   +2 more sources

Correction: Single-Center Experience with Sacubitril/Valsartan in Patients with Congenital Heart Disease. [PDF]

Pediatr Cardiol
Konduri A, Duimstra A, Lowery R, Yu S, Huebschman A, Crandall B, Hunter T, Lim HM, McCormick AD, Schumacher KR, Peng DM.   +10 more
europepmc   +1 more source

Subanalyses in HFmrEF Patients of Asian Ethnicity. [PDF]

JACC Asia
Du X.
europepmc   +1 more source

Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNis) in High-Output Heart Failure in a Young Hemodialysis Patient: Synergistic or Cumulative Effect? [PDF]

Cureus
Silva SR, Soares E, Natário A, Gama A, Bernardo T.   +4 more
europepmc   +1 more source

Different aspects of pharmacological heart failure treatment. [PDF]

Eur Heart J Cardiovasc Pharmacother
Agewall S.
europepmc   +1 more source

Multicenter, Randomized, Double-blind, Double Dummy, Parallel Group, Active-controlled 8-week Study and 8-week Open Label Extension to Evaluate the Effect of Initiation of Sacubitril/Valsartan on Objective Measures of Waking Activity and Sleep, as Health-related Quality of Life Functions in Subjects With Heart Failure and Reduced Ejection Fraction (AWAKE-HF).

Novartis
openalex   +1 more source

Cognitive Safety and Outcomes of Pharmacological Management in Heart Failure: A Systematic Review. [PDF]

Pharmaceuticals (Basel)
Balcerzak W, Poczatek G, Gorzkowska A, Blach A, Jurkiewicz M, Lasek-Bal A.   +5 more
europepmc   +1 more source